o)methyl)naphthalene-1,4-dione showed high activity against Candida albicans ATCC 10231, with minimal inhibitory concentrations (MICs) and minimal fungicidal concentrations (MFCs) ranging from 20 to 330 and from 80 to 330 µg mL-1, respectively. Moreover, they also showed a mechanism of action on exogenous ergosterol. Therapeutic concentrations (CC50) of 2-hydroxy-3-((2-hydroxyphenyl)(pyrrolidin-1-
羟基
萘醌,例如Lawone(2-hydroxy-1,4-naphthoquinone)已被证明是有效的抗真菌剂。通过肉汤微稀释法测试了这些化合物对酵母标准品和临床菌株的抗真菌活性。在合成的劳森酮衍
生物中,2-羟基-3-((2-羟基苯基)(
吡咯烷-1-基)甲基)
萘-1,4-二酮,2-羟基-3-(((4-
硝基苯基)
氨基) (苯基)甲基)
萘-1,4-二酮和2-羟基-3-((2-羟基苯基)((4-
硝基苯基)
氨基)甲基)
萘-1,4-二酮显示出对白色念珠菌A
TCC 10231的高活性,最小抑菌浓度(MIC)和最小杀真菌浓度(MFCs)分别为20至330和80至330 µg mL-1。此外,它们还显示了对外源
麦角固醇的作用机理。2-羟基-3-((2-羟基苯基)(
吡咯烷-1-基)甲基)
萘-1,4-二酮,2-羟基-3-(((4-
硝基苯基)
氨基)的治疗浓度(CC50) (苯基)甲基)
萘-1,4-二酮和2-羟基